RecruitingNCT04867408

Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease (EVEREST - IBD)

EVEREST - IBD: Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease


Sponsor

Hull University Teaching Hospitals NHS Trust

Enrollment

4,000 participants

Start Date

Sep 17, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy


Eligibility

Min Age: 16 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is building an image database from routine endoscopy (camera examinations of the gut) to develop and train AI tools that can automatically assess the severity of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. **You may be eligible if...** - You are 16 years or older - You are scheduled for a routine endoscopy (colonoscopy or similar procedure) as part of your normal medical care - You consent to having your anonymized endoscopy images used for research **You may NOT be eligible if...** - You are under 16 years old - You are unable to give informed consent - You do not want your images used for research Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hull Royal Infirmary

Hull, East Yorkshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04867408